HK1039745A1 - 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶 - Google Patents
用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶Info
- Publication number
- HK1039745A1 HK1039745A1 HK02100158.6A HK02100158A HK1039745A1 HK 1039745 A1 HK1039745 A1 HK 1039745A1 HK 02100158 A HK02100158 A HK 02100158A HK 1039745 A1 HK1039745 A1 HK 1039745A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- combination
- acetylcholinesterase inhibitor
- atypical antipsychotic
- improving cognition
- cognition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98203454 | 1998-10-16 | ||
PCT/EP1999/007804 WO2000023057A2 (en) | 1998-10-16 | 1999-10-12 | Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1039745A1 true HK1039745A1 (zh) | 2002-05-10 |
Family
ID=8234219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02100158.6A HK1039745A1 (zh) | 1998-10-16 | 2002-01-10 | 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶 |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1121131A2 (xx) |
JP (1) | JP2002527469A (xx) |
KR (1) | KR20010072878A (xx) |
CN (1) | CN1367697A (xx) |
AU (1) | AU6472799A (xx) |
BG (1) | BG105302A (xx) |
BR (1) | BR9914419A (xx) |
CA (1) | CA2345767A1 (xx) |
EE (1) | EE200100136A (xx) |
HK (1) | HK1039745A1 (xx) |
HR (1) | HRP20010262A2 (xx) |
HU (1) | HUP0103781A3 (xx) |
ID (1) | ID28441A (xx) |
IL (1) | IL142588A0 (xx) |
NO (1) | NO20011403D0 (xx) |
PL (1) | PL348107A1 (xx) |
SK (1) | SK4592001A3 (xx) |
TR (1) | TR200101082T2 (xx) |
WO (1) | WO2000023057A2 (xx) |
ZA (1) | ZA200103081B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
JP5067998B2 (ja) | 2001-10-30 | 2012-11-07 | ノバルティス アーゲー | イロペリドンおよび星形ポリマーのデポー製剤 |
GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
US20050232990A1 (en) * | 2003-12-31 | 2005-10-20 | Garth Boehm | Donepezil formulations |
AU2004325725A1 (en) * | 2004-12-10 | 2006-06-22 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
CA2679446C (en) | 2007-03-01 | 2016-05-17 | Probiodrug Ag | New use of glutaminyl cyclase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
EP2533645B1 (en) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤 |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
EP2968220B1 (en) | 2013-03-15 | 2021-05-05 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE183084T1 (de) * | 1991-05-14 | 1999-08-15 | Ernir Snorrason | Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
DK1011678T3 (da) * | 1997-08-11 | 2008-05-05 | Univ South Florida | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser |
EP2338482A3 (en) * | 1998-04-14 | 2011-12-21 | The General Hospital Corporation | Methods for treating neuropsychiatric disorders |
-
1999
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Application Discontinuation
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Application Discontinuation
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403D0/no not_active Application Discontinuation
- 2001-04-10 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
-
2002
- 2002-01-10 HK HK02100158.6A patent/HK1039745A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU6472799A (en) | 2000-05-08 |
NO20011403L (no) | 2001-03-20 |
SK4592001A3 (en) | 2001-12-03 |
EE200100136A (et) | 2002-06-17 |
NO20011403D0 (no) | 2001-03-20 |
WO2000023057A3 (en) | 2000-07-27 |
HRP20010262A2 (en) | 2002-06-30 |
ZA200103081B (en) | 2002-07-12 |
WO2000023057A2 (en) | 2000-04-27 |
HUP0103781A2 (hu) | 2002-03-28 |
TR200101082T2 (tr) | 2001-09-21 |
BR9914419A (pt) | 2001-06-26 |
ID28441A (id) | 2001-05-24 |
BG105302A (en) | 2001-11-30 |
HUP0103781A3 (en) | 2003-09-29 |
PL348107A1 (en) | 2002-05-06 |
EP1121131A2 (en) | 2001-08-08 |
IL142588A0 (en) | 2002-03-10 |
JP2002527469A (ja) | 2002-08-27 |
KR20010072878A (ko) | 2001-07-31 |
CA2345767A1 (en) | 2000-04-27 |
CN1367697A (zh) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1039745A1 (zh) | 用於改善識別的非典型抗精神病藥和乙酰膽碱酯酶 | |
IL146474A0 (en) | Benzothiazinone and benzoxazinone compounds | |
EP1233007A4 (en) | INTERMEDIATE LAYER FOR COMPOSITE GLASS AND COMPOSITE GLASS | |
GB9906166D0 (en) | Coverable container | |
HK1034818A1 (en) | Inverter | |
EP1312379A4 (en) | FIBRINOGENIC REDUCTION AGENTS | |
GB9805184D0 (en) | Table construction | |
GB2345528B (en) | Annealing welded parts | |
GB0025569D0 (en) | Cold box | |
GB9817085D0 (en) | Drinks bottle accessory | |
EP1306903A4 (en) | INVERTER | |
GB0003496D0 (en) | Improved worktable | |
GB9900182D0 (en) | Combination continental quilt | |
HK1021449A1 (en) | Table tap | |
GB9820159D0 (en) | Resealable beverage can | |
GB9922674D0 (en) | Key tappers | |
GB9804075D0 (en) | Disgorger torch | |
PL328097A1 (en) | Regenerative beverage of high calorific value | |
LT98156A (en) | Alcoholic beverage composition | |
GB9915337D0 (en) | Rail lholder | |
GB0024847D0 (en) | Inverter | |
CA82933S (en) | Beverage can | |
PL108743U1 (en) | Table-dispenser for beverages | |
GB9807307D0 (en) | Wine warmer | |
PL324941A1 (en) | Combination transformer |